Guardion Health Sciences (GHSI) Stock Continues Skyward

Guardion Health Sciences GHSI Stock News

Guardion Health Sciences Inc (NASDAQ: GHSI) is up more than 25% this morning, adding to the recent gains that we’ve seen in the stock. The most recent news was associated with a Malasian listed company selecting GHSI to develop an immune-supportive formula, which was announced two days ago. Nonetheless, it seems as thought the stock is one of a long list that are benefiting from the continued spread of the Wuhan coronavirus. Here’s the scoop:

Stop wasting your time! start finding winning trades in minutes with Trade Ideas!

GHSI Stock Continues Skyward As Coronavirus Spreads

As mentioned above, Guardian Health Sciences was recently selected by Ho Wah Genting Berhad (HWGB) to develop a proprietary immune-supportive formula. In the release, the company said that the formula is designed to provide both immuno-supportive and anti-inflammatory benefits to users.

While GHSI specifically said that the formula is not tested or intended to specifically address COVID-19, many are making the connection between immuno-supportive supplements and opportunity in the coronavirus market.

This seems to be what’s driving the upward movement in the value of GHSI. As a reminder, the company recently aquired the NutriGuard brand. With this brand came a long list of supplements for various areas of healthcare. The timing of this acquisition couldn’t be more perfect.

Shortly after the acquisition of NutriGuard, the Wuhan Coronavirus, also known as COVID-19 started to make headlines. Of course, the spread of this deadly virus is causing fear among consumers around the world.

Considering this, consumers are more likely to start taking advantage of supplements that can boost the immune system. After all, considering the fact that there are currently no approved vaccines or treatments for the virus, our immune system is the first line of defense.

Are More Gains To Come?

In my view, we’re seeing the tip of the iceberg when it comes to gains in Guardion Health Sciences. As mentioned above, the acquisition of NutriGuard couldn’t have happened at a better time.

Moreover, it’s worth mentioning that experts are expecting that COVID-19 will continue to spread globally.

As the virus continues to spread and consumers continue to look for ways to protect themselves, demand for NutriGuard supplements for immune health will likely climb. Of course, this will directly relate to increasing revenue at GHSI and a large opportunity for investors.

Stop wasting your time! start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story!

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.